Remove Atherosclerosis Remove Coronary Artery Disease Remove Plaque
article thumbnail

Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake

Journal of Clinical Investigation - Cardiology

Mitochondrial dysfunction fuels vascular inflammation and atherosclerosis. However, the role of MICU1 in vascular inflammation and atherosclerosis remains unknown. Here, we report that endothelial MICU1 prevents vascular inflammation and atherosclerosis by maintaining mitochondrial homeostasis.

article thumbnail

New genetic risk score identifies individuals at risk for heart disease who may benefit most from cholesterol-lowering therapies

Science Daily - Heart Disease

Coronary artery disease (CAD), or the narrowing of the coronary arteries, is the leading cause of morbidity and mortality throughout the world. Researchers developed a polygenic risk score that examines genes associated with EC function to identify individuals with higher CAD risk.

article thumbnail

How To Reverse Coronary Artery Disease With Lifestyle Measures

Dr. Paddy Barrett

Reversing or regressing coronary artery disease is possible. You cannot eliminate the plaque entirely, but multiple clinical trials have shown plaque regression using high-intensity cholesterol-lowering treatments, which I have discussed previously. REVERSAL Investigators. 2004 Mar 3;291(9):1071-80.

article thumbnail

New 'atherosclerosis atlas' sheds light on heart attacks, strokes

Medical Xpress - Cardiology

University of Virginia School of Medicine researchers have created an "atlas of atherosclerosis" that reveals, at the level of individual cells, critical processes responsible for forming the harmful plaque buildup that causes heart attacks, strokes, and coronary artery disease.

article thumbnail

New 'Atherosclerosis Atlas' Sheds Light on Heart Attacks, Strokes

DAIC

MILLER, PHD, LED THE DEVELOPMENT OF A NEW "ATHEROSCLEROSIS ATLAS" THAT DETAILS, AT THE LEVEL OF INDIVIDUAL CELLS, CRITICAL PROCESSES RESPONSIBLE FOR FORMING THE HARMFUL PLAQUE BUILDUP THAT CAUSES HEART ATTACKS, STROKES AND CORONARY ARTERY DISEASE. THE UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE'S CLINT L.

article thumbnail

Trial Results: Low-Dose Colchicine HelpsTreat Cardiovascular Disease

DAIC

mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J. Budoff, M.D.,

article thumbnail

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

DAIC

Image courtesy: Cleerly christine.book Tue, 02/13/2024 - 11:47 February 13, 2024 — Cleerly , a digital healthcare company focused on artificial intelligence (AI)-driven heart disease diagnosis, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan.